Browsing by Author Sala, A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
2012A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastomaSottile, F; Gnemmi, I; Cantilena, S; D'Acunto, WC; Sala, A
2009Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomasChakya, O; Corvetta, D; Dews, M; Caccamo, AE; Piotrowska, I, et al
2016Cutaneous cylindroma: it's all about MYBCorda, G; Sala, A
2015Frizzled receptor 6 and risk of metastatic recurrence in early triple negative breast cancerSala, A; Corda, Gabriele
2011Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomasCantilena, S; Pastorino, F; Pezzolo, A; Chayka, O; Pistoia, V, et al
2015Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cellsChayka, O; D'Acunto, CW; Middleton, O; Arab, M; Sala, A
2013Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: Functional and therapeutic implicationsCorvetta, D; Chayka, O; Gherardi, S; D'Acunto, CW; Cantilena, S, et al
2013Polyphenon E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cellsSantilli, G; Piotrowska, I; Cantilena, S; Chayka, O; D'Alicarnasso, M, et al
2016A promyelocytic leukemia protein-thrombospondin 2 axis and the risk of relapse in neuroblastomaDvorkina, M; Nieddu, V; Chakelam, S; Pezzolo, A; Cantilena, S, et al
2011The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60Chaiwatanasirikul, KA; Sala, A